Treatment Registry
TR-0211 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Livv · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$239

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Monthly plan · recorded initial monthly payment$239

Added from the figures recorded below.

Price

TermPublished rateCharged today
Monthly plan

“Monthly plan $239/month”

Per month$239Charged today$239
3 month plan

“3 month plan $219/month”

$219Published figureCharged todayNot verified
6 month plan

“6 month plan $199/month”

$199Published figureCharged todayNot verified
Price sources
Visit Livv

We earn nothing from this link. It opens Livv's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
CancellationCancellations take effect at the end of the current billing period. If applicable, you'll continue receiving your medication through the remainder of that paid cycle. Refunds are not typically offered.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from joinlivv.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Pricing page copy says 'One price covers your consultation, medication, and shipping with no hidden fees' so the listed per-month figures are program prices, not a separate membership fee. Form (vial vs. pen) is never stated for either drug.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0211
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Livv

All Livv programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Livv — compounded tirzepatide (TR-0211). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0211

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.